Business
– The agreement gives Medivation the license to develop and commercialize Curetech’s pidilizumab cancer treatment. – Medivation has decided to exercise the option...
Hi, what are you looking for?
Jewish Business News
All posts tagged "Clal Biotechnology Industries Ltd. (TASE: CBI)"
Business
– Investor Mori Arkin: If Hyperion overlooked weak points in the data, it’s their mistake. – The Andromeda affair, in which an Israeli company...
Leadership
– The donation will fund drug development, computer science, cyber research, movie production and more. – The Blavatnik Family Foundation is donating $20...
Business
– Novartis had signed an MOU to acquire the stem cell treatment company for up to $600 million. – Elbit Medical Technologies Ltd. (TASE:EMTC)...
IPOs
– The burns and wounds treatment developer is issuing 5 million shares at $14 each. – – Burns and wounds treatment developer Mediwound will begin trading...
Business
– The stem cell developer could be acquired at a company value of hundreds of millions of dollars. – Stem cell therapies developer Gamida-Cell...
Business
– Clal Biotechnology Industries Ltd. (TASE: CBI) has signed a non-binding letter of intent to sell diabetes treatment developer Andromeda Biotech Ltd. to a US pharmaceutical company for...
Business
– Teva will receive $72 million from future sales or from the proceeds of an exit, if any. Diapep277 Slowing the Progression of Type 1...
IPOs
– The burn and wound treatment company MediWound plans to raise $100m on Nasdaq at a $400 million valuation. – In the coming weeks, several Israeli...
Business
– Blavatnik’s Access Industries, which owns 49.9% of Clal Industries, will buy the public’s holdings under an offer to purchase. – – / By...